发明名称 Therapeutic use of mucin glycans
摘要 A therapeutic formulation containing mucin glycans derived from one or a number of nutritionally appropriate sources is described.
申请公布号 US8795746(B2) 申请公布日期 2014.08.05
申请号 US201213397556 申请日期 2012.02.15
申请人 The Board of Trustees of the Leland Stanford Junior University 发明人 Sonnenburg Justin L.
分类号 A23C9/20;A23L1/30;C13K13/00 主分类号 A23C9/20
代理机构 Bozicevic, Field & Francis LLP 代理人 Bozicevic, Field & Francis LLP ;Sherwood Pamela J.
主权项 1. An infant formula supplement comprising: (i) mammalian mucin glycans released and isolated from the protein component of mammalian mucins purified to comprise less than 10% by weight protein, which mucin glycans are a heterogenous mixture of linear and branched oligosaccharides from about 2 to about 10 saccharide subunits in length, that selectively stimulate growth of desirable gut microorganisms comprising Bacteroides species, wherein the mucin glycans upregulate a set of polysaccharide utilization loci (PULs) in said Bacteroides species similar to those PULs upregulated in response to human milk oligosaccharides (HMO); and optionally (ii) at least one human milk oligosaccharide (HMO).
地址 Palo Alto CA US